Edit |   |
---|---|
Antigenic Specificity | CD52, Human (Tarextumab biosimilar) |
Clone | Tarextumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 kappa lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD52 Recombinant Antibody (Tarextumab). Tarextumab (formerly OMP-59R5) is a fully human monoclonal antibody targeting the Notch 2/3 receptors. It is being tested as a possible treatment for cancer. In January 2015, the US FDA granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and lung cancer. Two early stage clinical trials have reported encouraging results. |
Immunogen | n/a |
Other Names | Anti-CD52 Recombinant Antibody, Research Grade Tarextumab, Anti-Human CD52 Recombinant Antibody(Tarextumab), OMP-59R5, Antibody Drug Analogues, Monoclonal Antibody, YR1312, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1359940-55-8 |
Catalog # | YR1312 |
Price | please inquire |
Order / More Info | CD52, Human (Tarextumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |